Kiora Pharmaceuticals Inc (KPRX)

• $3.41

  $3.54

  $3.41
  

  0.0%

  Downside

  Day's Volatility :3.66%

  Upside

  3.66%

  
• $3.00

  $8.98

  $3.41
  

  12.02%

  Downside

  52 Weeks Volatility :66.6%

  Upside

  62.04%

  

Returns

What analysts predicted

Upside of 789.44%

• AIGH Capital Management, LLC

  8.60%

• Rosalind Advisors, Inc.

  8.60%

• Nantahala Capital Management, LLC

  7.11%

• Alyeska Investment Group, L.P.

  6.09%

• ADAR1 Capital Management LLC

  5.81%

• Velan Capital Investment Management LP

  4.11%

traded on nasdaq capital market, stock symbol eyeg, eyegate is a clinical-stage specialty pharmaceutical company that develops and commercializes products using two proprietary platform technologies for treating diseases and disorders of the eye. our most advanced platform is based on a crosslinked thiolated carboxymethyl hyaluronic acid (“cmha-s”), a modified form of the natural polymer hyaluronic acid (“ha”), which is a gel that possesses unique physical and chemical properties such as hydrating and healing when applied to the ocular surface. our first cmha-s-based product candidate, the eyegate ocular bandage gel (“obg”), is a topically applied eye drop formulation that has completed its first-in-man clinical trial for the healing and lubricating of large epithelial defects following treatment after photorefractive keratectomy (“prk”) surgery. our initial product candidate from our second platform is egp-437, incorporates a reformulated topically active corticosteroid, dexamethasone